 | • レポートコード：QYR9ST03957 • 出版社/出版日：QYResearch / 2019年9月2日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥569,400 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,138,800 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、非血液癌の世界市場について調査・分析し、非血液癌の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、手術、放射線療法、その他）、用途別（病院、腫瘍治療センター、外来手術センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の非血液癌市場動向 ・主要企業別マーケットシェア ・非血液癌の種類別市場規模2014-2019 （化学療法、手術、放射線療法、その他） ・非血液癌の用途別市場規模2014-2019 （病院、腫瘍治療センター、外来手術センター、その他） ・非血液癌の北米市場：主要企業・種類別/用途別市場規模 ・非血液癌のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・非血液癌の中国市場：主要企業・種類別/用途別市場規模 ・非血液癌の日本国内市場：主要企業・種類別/用途別市場規模 ・非血液癌の東南アジア市場：主要企業・種類別/用途別市場規模 ・非血液癌のインド市場：主要企業・種類別/用途別市場規模 ・非血液癌の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Novartis、Pfizer、Bristol-Myers Squibb、Johnson & Johnson、Roche、Amgen、Astellas Pharma） ・非血液癌の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient.North America has the huge number of population suffering from cancer, according to National Cancer Institute which come under the U.S health, the statistic published in 2016 around 1,685,210 new cancer is diagnosed and 595,690 people died due to cancer. Cancer is the second important cause of death in Europe as per the WHO Regional Office for Europe in 2012, around 3.7 million new cases of cancer occur in Europe and 1.9 million death each year. Same as for Asia Pacific and the creating the awareness is also the necessary aspect to be consider.
In 2018, the global Non-Hematological Cancers market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Non-Hematological Cancers status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Hematological Cancers development in United States, Europe and China.
The key players covered in this study
Novartis
Pfizer
Bristol-Myers Squibb
Johnson & Johnson
Roche
Amgen
Astellas Pharma
…
Market segment by Type, the product can be split into
Chemotherapy
Surgery
Radiation Therapy
Others
Market segment by Application, split into
Hospitals
Oncology Treatment Centre
Ambulatory Surgery Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Non-Hematological Cancers status, future forecast, growth opportunity, key market and key players.
To present the Non-Hematological Cancers development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Non-Hematological Cancers are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-Hematological Cancers Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Surgery
1.4.4 Radiation Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Non-Hematological Cancers Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Oncology Treatment Centre
1.5.4 Ambulatory Surgery Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Non-Hematological Cancers Market Size
2.2 Non-Hematological Cancers Growth Trends by Regions
2.2.1 Non-Hematological Cancers Market Size by Regions (2014-2025)
2.2.2 Non-Hematological Cancers Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Non-Hematological Cancers Market Size by Manufacturers
3.1.1 Global Non-Hematological Cancers Revenue by Manufacturers (2014-2019)
3.1.2 Global Non-Hematological Cancers Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Non-Hematological Cancers Market Concentration Ratio (CR5 and HHI)
3.2 Non-Hematological Cancers Key Players Head office and Area Served
3.3 Key Players Non-Hematological Cancers Product/Solution/Service
3.4 Date of Enter into Non-Hematological Cancers Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Non-Hematological Cancers Market Size by Type (2014-2019)
4.2 Global Non-Hematological Cancers Market Size by Application (2014-2019)
5 United States
5.1 United States Non-Hematological Cancers Market Size (2014-2019)
5.2 Non-Hematological Cancers Key Players in United States
5.3 United States Non-Hematological Cancers Market Size by Type
5.4 United States Non-Hematological Cancers Market Size by Application
6 Europe
6.1 Europe Non-Hematological Cancers Market Size (2014-2019)
6.2 Non-Hematological Cancers Key Players in Europe
6.3 Europe Non-Hematological Cancers Market Size by Type
6.4 Europe Non-Hematological Cancers Market Size by Application
7 China
7.1 China Non-Hematological Cancers Market Size (2014-2019)
7.2 Non-Hematological Cancers Key Players in China
7.3 China Non-Hematological Cancers Market Size by Type
7.4 China Non-Hematological Cancers Market Size by Application
8 Japan
8.1 Japan Non-Hematological Cancers Market Size (2014-2019)
8.2 Non-Hematological Cancers Key Players in Japan
8.3 Japan Non-Hematological Cancers Market Size by Type
8.4 Japan Non-Hematological Cancers Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Non-Hematological Cancers Market Size (2014-2019)
9.2 Non-Hematological Cancers Key Players in Southeast Asia
9.3 Southeast Asia Non-Hematological Cancers Market Size by Type
9.4 Southeast Asia Non-Hematological Cancers Market Size by Application
10 India
10.1 India Non-Hematological Cancers Market Size (2014-2019)
10.2 Non-Hematological Cancers Key Players in India
10.3 India Non-Hematological Cancers Market Size by Type
10.4 India Non-Hematological Cancers Market Size by Application
11 Central & South America
11.1 Central & South America Non-Hematological Cancers Market Size (2014-2019)
11.2 Non-Hematological Cancers Key Players in Central & South America
11.3 Central & South America Non-Hematological Cancers Market Size by Type
11.4 Central & South America Non-Hematological Cancers Market Size by Application
12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-Hematological Cancers Introduction
12.1.4 Novartis Revenue in Non-Hematological Cancers Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-Hematological Cancers Introduction
12.2.4 Pfizer Revenue in Non-Hematological Cancers Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-Hematological Cancers Introduction
12.3.4 Bristol-Myers Squibb Revenue in Non-Hematological Cancers Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-Hematological Cancers Introduction
12.4.4 Johnson & Johnson Revenue in Non-Hematological Cancers Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-Hematological Cancers Introduction
12.5.4 Roche Revenue in Non-Hematological Cancers Business (2014-2019)
12.5.5 Roche Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-Hematological Cancers Introduction
12.6.4 Amgen Revenue in Non-Hematological Cancers Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Astellas Pharma
12.7.1 Astellas Pharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-Hematological Cancers Introduction
12.7.4 Astellas Pharma Revenue in Non-Hematological Cancers Business (2014-2019)
12.7.5 Astellas Pharma Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Non-Hematological Cancers Key Market Segments
Table Key Players Non-Hematological Cancers Covered
Table Global Non-Hematological Cancers Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Non-Hematological Cancers Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Surgery Figures
Table Key Players of Surgery
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Others Figures
Table Key Players of Others
Table Global Non-Hematological Cancers Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Oncology Treatment Centre Case Studies
Figure Ambulatory Surgery Centers Case Studies
Figure Others Case Studies
Figure Non-Hematological Cancers Report Years Considered
Table Global Non-Hematological Cancers Market Size 2014-2025 (Million US$)
Figure Global Non-Hematological Cancers Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Non-Hematological Cancers Market Size by Regions 2014-2025 (Million US$)
Table Global Non-Hematological Cancers Market Size by Regions 2014-2019 (Million US$)
Table Global Non-Hematological Cancers Market Share by Regions 2014-2019
Figure Global Non-Hematological Cancers Market Share by Regions 2014-2019
Figure Global Non-Hematological Cancers Market Share by Regions 2019
Table Market Top Trends
Table Global Non-Hematological Cancers Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Non-Hematological Cancers Market Share by Manufacturers (2014-2019)
Figure Global Non-Hematological Cancers Market Share by Manufacturers in 2018
Table Global Non-Hematological Cancers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-Hematological Cancers Product/Solution/Service
Table Date of Enter into Non-Hematological Cancers Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-Hematological Cancers Market Size by Type (2014-2019) (Million US$)
Table Global Non-Hematological Cancers Market Size Share by Type (2014-2019)
Figure Global Non-Hematological Cancers Market Size Market Share by Type (2014-2019)
Table Global Non-Hematological Cancers Market Size by Application (2014-2019) (Million US$)
Table Global Non-Hematological Cancers Market Size Share by Application (2014-2019)
Figure Global Non-Hematological Cancers Market Size Market Share by Application (2014-2019)
Figure Global Non-Hematological Cancers Revenue Market Share by Application in 2018
Figure United States Non-Hematological Cancers Market Size 2014-2019 (Million US$)
Table United States Key Players Non-Hematological Cancers Revenue (2018-2019) (Million US$)
Table United States Key Players Non-Hematological Cancers Market Share (2018-2019)
Table United States Non-Hematological Cancers Market Size by Type (2014-2019) (Million US$)
Table United States Non-Hematological Cancers Market Share by Type (2014-2019)
Table United States Non-Hematological Cancers Market Size by Application (2014-2019) (Million US$)
Table United States Non-Hematological Cancers Market Share by Application (2014-2019)
Figure Europe Non-Hematological Cancers Market Size 2014-2019 (Million US$)
Table Europe Key Players Non-Hematological Cancers Revenue (2018-2019) (Million US$)
Table Europe Key Players Non-Hematological Cancers Market Share (2018-2019)
Table Europe Non-Hematological Cancers Market Size by Type (2014-2019) (Million US$)
Table Europe Non-Hematological Cancers Market Share by Type (2014-2019)
Table Europe Non-Hematological Cancers Market Size by Application (2014-2019) (Million US$)
Table Europe Non-Hematological Cancers Market Share by Application (2014-2019)
Figure China Non-Hematological Cancers Market Size 2014-2019 (Million US$)
Table China Key Players Non-Hematological Cancers Revenue (2018-2019) (Million US$)
Table China Key Players Non-Hematological Cancers Market Share (2018-2019)
Table China Non-Hematological Cancers Market Size by Type (2014-20189) (Million US$)
Table China Non-Hematological Cancers Market Share by Type (2014-2019)
Table China Non-Hematological Cancers Market Size by Application (2014-2019) (Million US$)
Table China Non-Hematological Cancers Market Share by Application (2014-2019)
Figure Japan Non-Hematological Cancers Market Size 2014-2019 (Million US$)
Table Japan Key Players Non-Hematological Cancers Revenue (2018-2019) (Million US$)
Table Japan Key Players Non-Hematological Cancers Market Share (2018-2019)
Table Japan Non-Hematological Cancers Market Size by Type (2014-2019) (Million US$)
Table Japan Non-Hematological Cancers Market Share by Type (2014-2019)
Table Japan Non-Hematological Cancers Market Size by Application (2014-2019) (Million US$)
Table Japan Non-Hematological Cancers Market Share by Application (2014-2019)
Figure Southeast Asia Non-Hematological Cancers Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Non-Hematological Cancers Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Non-Hematological Cancers Market Share (2018-2019)
Table Southeast Asia Non-Hematological Cancers Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Non-Hematological Cancers Market Share by Type (2014-2019)
Table Southeast Asia Non-Hematological Cancers Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Non-Hematological Cancers Market Share by Application (2014-2019)
Figure India Non-Hematological Cancers Market Size 2014-2019 (Million US$)
Table India Key Players Non-Hematological Cancers Revenue (2018-2019) (Million US$)
Table India Key Players Non-Hematological Cancers Market Share (2018-2019)
Table India Non-Hematological Cancers Market Size by Type (2014-2019) (Million US$)
Table India Non-Hematological Cancers Market Share by Type (2014-2019)
Table India Non-Hematological Cancers Market Size by Application (2014-2019) (Million US$)
Table India Non-Hematological Cancers Market Share by Application (2014-2019)
Figure Central & South America Non-Hematological Cancers Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Non-Hematological Cancers Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Non-Hematological Cancers Market Share (2018-2019)
Table Central & South America Non-Hematological Cancers Market Size by Type (2014-2019) (Million US$)
Table Central & South America Non-Hematological Cancers Market Share by Type (2014-2019)
Table Central & South America Non-Hematological Cancers Market Size by Application (2014-2019) (Million US$)
Table Central & South America Non-Hematological Cancers Market Share by Application (2014-2019)
Table Novartis Company Details
Table Novartis Revenue in Non-Hematological Cancers Business (2014-2019) (Million US$)
Figure Novartis Revenue Growth Rate in Non-Hematological Cancers Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Non-Hematological Cancers Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Non-Hematological Cancers Business (2014-2019)
Table Pfizer Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Non-Hematological Cancers Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Non-Hematological Cancers Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Non-Hematological Cancers Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Non-Hematological Cancers Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Roche Company Details
Table Roche Revenue in Non-Hematological Cancers Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Non-Hematological Cancers Business (2014-2019)
Table Roche Recent Development
Table Amgen Company Details
Table Amgen Revenue in Non-Hematological Cancers Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Non-Hematological Cancers Business (2014-2019)
Table Amgen Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Non-Hematological Cancers Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Non-Hematological Cancers Business (2014-2019)
Table Astellas Pharma Recent Development
Table Global Non-Hematological Cancers Market Size by Regions (Million US$) 2019-2025
Figure Global Non-Hematological Cancers Market Size Share by Regions (2019-2025)
Figure Global Non-Hematological Cancers Market Size Share by Regions in 2025
Figure United States Non-Hematological Cancers Market Size Forecast (2019-2025)(Million USD)
Figure Europe Non-Hematological Cancers Market Size Forecast (2019-2025)(Million USD)
Figure China Non-Hematological Cancers Market Size Forecast (2019-2025)(Million USD)
Figure Japan Non-Hematological Cancers Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Non-Hematological Cancers Market Size Forecast (2019-2025)(Million USD)
Figure India Non-Hematological Cancers Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Non-Hematological Cancers Market Size Forecast (2019-2025)(Million USD)
Table Global Non-Hematological Cancers Market Size by Product (2019-2025) (Million US$)
Figure Global Non-Hematological Cancers Market Size by Product (2019-2025)
Figure Global Non-Hematological Cancers Market Size by Product in 2025
Table Global Non-Hematological Cancers Market Size by Application (2019-2025) (Million US$)
Figure Global Non-Hematological Cancers Market Size by Application (2019-2025)
Figure Global Non-Hematological Cancers Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
婦人科癌の世界市場：市場規模・現状・予測 Gynecological cancers are characterized by uncontrolled growth and spread of abnormal cells. The growth of the global gynecological cancer drugs market is driven by factors such as increase in incidence of gynecological cancers, growth in importance of targeted drug therapies, rise in investment fro…- 外来手術センターの世界市場：インサイト・予測 Ambulatory surgery centers or outpatient surgery centers are alternatives to hospital-based outpatient procedures that provide health care facilities. These centers are cost-effective and offer quality care & positive patient outcome.The global Ambulatory Surgery Centre market is valued at xx millio…
- 血液悪性腫瘍の世界市場：市場規模・現状・予測 Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system.In 2018, the global Hematological Malignancies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, wit…
- 血液疾患用薬物および診断の世界市場：市場規模・現状・予測 Hematological disorders deal with blood related diseases and generally affect the quantity or functionality of the cells or proteins present in the blood.Some blood disorders result in the increase of the number of cells in blood such as anemia, leukopenia while other cause the number of blood cells…
- 血液疾患診断及び治療の世界市場：市場規模・現状・予測 Hematology, a branch of medicine, deals with the prevention, diagnosis, and treatment of blood diseases. It includes problems associated with red blood cells (RBCs), white blood cells (WBCs), platelets, bone marrow, blood vessels, spleen, lymph nodes, and proteins involved in bleeding and clotting p…